MedTrace Logo

Assessment of Quadriceps Femoris Muscle Function in Patients After Arthroscopic Knee Surgery in Outpatient Rehabilitation

NCT06870825 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2025-03-11

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a high intensity magnetic field is an effective way to treat quadriceps muscle atrophy after knee arthroscopic surgery in adult patients. The main questions it aims to answer are:

Is high intensity magnetic field muscle stimulation is an effective way to treat quadriceps muscle atrophy Is high intensity magnetic field muscle stimulation is more effective and more tolerable option for quadriceps muscle stimulation than transcutaneous muscle electrical stimulation Researchers will compare high intensity magnetic field muscle stimulation to transcutaneous muscle electrical stimulation and control group, to see if high intensity magnetic field muscle stimulation works to treat quadriceps muscle atrophy.

Participants will:

receive high intensity magnetic field or transcutaneous muscle electrical stimulation 1 time/day for 14 days, Visit the rehabilitation department for testing before/after and 1 month after rehabilitation.

Conditions

  • Meniscus Injury
  • Meniscus Tear
  • Arthroscopic Knee Surgeries
  • ACL Injuries

Interventions

DEVICE

High-intensity Magnetic Field Muscle Stimulation

1. The procedure is performed for 20 min., 1k/d, 5k/week, a total of 14 times (rehabilitation duration 14 days). 2. Parameters: applied parameters according to the manufacturer's specified program for muscle stimulation: "muscle strengthening" program 3. Stimulation site: quadriceps femoris muscle, applied above the motor point approximately 60% of the distance from the upper medial border of the patella to the anterior upper wing of the iliac bone. 4. device: BLT Super Inductive System * Along with muscle stimulation techniques, all subjects will undergo a standardized outpatient rehabilitation plan.

DEVICE

Transcutaneous Neuromuscular Electrical Stimulation

1. the procedure is performed for 20 min., 1k/d, 5k/week, a total of 14 times (rehab. duration 14 days). 2. Parameters: applied parameters according to the manufacturer's specified program for muscle stimulation (EMS, P3) 3. Stimulation site: quadriceps femoris muscle, applied above the motor point. 4. device: ITO ES-5200 * Along with muscle stimulation techniques, all subjects will undergo a standardized outpatient rehabilitation plan.

Sponsors & Collaborators

  • Lithuanian University of Health Sciences

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2027-03-30
Completion
2027-08-01

Countries

  • Lithuania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06870825 on ClinicalTrials.gov